APA

Leighl N. B., Goss G. D., Lopez P. G., Burkes R. L., Dancey J. E., Rahim Y. H., Rudinskas L. C., Pouliot J. F., Rodgers A., Pond G. R. & Shepherd F. A. (20061025). Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer. : Lung cancer (Amsterdam, Netherlands).

Chicago

Leighl Natasha B, Goss G D, Lopez P G, Burkes R L, Dancey J E, Rahim Y H, Rudinskas L C, Pouliot J F, Rodgers A, Pond G R and Shepherd F A. 20061025. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer. : Lung cancer (Amsterdam, Netherlands).

Harvard

Leighl N. B., Goss G. D., Lopez P. G., Burkes R. L., Dancey J. E., Rahim Y. H., Rudinskas L. C., Pouliot J. F., Rodgers A., Pond G. R. and Shepherd F. A. (20061025). Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer. : Lung cancer (Amsterdam, Netherlands).

MLA

Leighl Natasha B, Goss G D, Lopez P G, Burkes R L, Dancey J E, Rahim Y H, Rudinskas L C, Pouliot J F, Rodgers A, Pond G R and Shepherd F A. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer. : Lung cancer (Amsterdam, Netherlands). 20061025.